NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis
Xiaohong Li(Central South University), Ziqiang Luo(Central South University)
American Journal of Physiology-Lung Cellular and Molecular Physiology
May 3, 2018
Cited by 51
Related Papers
Abnormal mitochondrial iron metabolism damages alveolar type II epithelial cells involved in bleomycin-induced pulmonary fibrosis
|Theranostics|2024|38
Two-Pore-Domain Potassium Channel TREK–1 Mediates Pulmonary Fibrosis through Macrophage M2 Polarization and by Direct Promotion of Fibroblast Differentiation
|Biomedicines|2023|19
NMDA receptor activation inhibits the protective effect of BM‑MSCs on bleomycin‑induced lung epithelial cell damage by inhibiting ERK signaling and the paracrine factor HGF
|International Journal of Molecular Medicine|2019|15